SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010634
Filing Date
2015-11-12
Accepted
2015-11-12 17:12:19
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20150930.htm 10-Q 1974456
2 EX-31.1 mcrb-ex311_6.htm EX-31.1 9224
3 EX-31.2 mcrb-ex312_7.htm EX-31.2 9215
4 EX-32.1 mcrb-ex321_8.htm EX-32.1 7344
5 EX-32.2 mcrb-ex322_9.htm EX-32.2 7359
  Complete submission text file 0001564590-15-010634.txt   6532355

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20150930.xml EX-101.INS 1194809
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20150930.xsd EX-101.SCH 49820
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20150930_cal.xml EX-101.CAL 36960
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20150930_def.xml EX-101.DEF 200796
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20150930_lab.xml EX-101.LAB 400128
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20150930_pre.xml EX-101.PRE 329016
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 151225852
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences